Insights - Within biotechnology and the broader healthcare sector, investor sentiment often reaches extremes. A company might be heralded as a revolution in medicine and see its … Continue Reading
Read nowLong Ideas - Shares of ViroPharma fell 6.9% on May 1 with the release of mixed first quarter results, also amidst a weak day for the biotechnology sector … Continue Reading
Read nowLong Ideas - Shares of Auxilium Pharmaceuticals (AUXL) fell nearly 13% on April 29 after the company released weak Q1 earnings, and are down around 12% since our … Continue Reading
Read nowLong Ideas - Since our last report on Alexion Pharmaceuticals (ALXN) on April 5, shares have remained flat as continued concerns about the company’s manufacturing facilities and Soliris’ … Continue Reading
Read nowLong Ideas - On April 22, after the close of trading, Illumina (ILMN) released its Q1 2013 earnings, delivering another solid quarter in the face of perceived uncertainty. … Continue Reading
Read nowLong Ideas - Since our last report on Achillion Pharmaceuticals (ACHN) in November, shares have turned up a muted performance, losing around 7%. Through February, shares rose steadily, … Continue Reading
Read nowLong Ideas - For many investors, the notion of investing in an OTC stock is difficult to grasp. Such stocks are often illiquid and volatile, however, painting with … Continue Reading
Read now